Digipath, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021
May 17, 2021 at 04:58 pm
Share
DigiPath, Inc. announced earnings results for the second quarter ended March 31, 2021. For the second quarter, the company announced sales was USD 633,160 compared to USD 754,982 a year ago. Operating income was USD 2,620 compared to operating loss of USD 594,270 a year ago. Net income was USD 18,201 compared to net loss of USD 609,143 a year ago. Basic eps - continuing operations was USD 0 compared to basic loss per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 1.133 million compared to USD 1.563 million a year ago. Operating loss was USD 345,644 compared to USD 806,136 a year ago. Net loss was USD 372,436 compared to USD 829,570 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago. Diluted eps - continuing operations was USD 0 compared to diluted loss per share from continuing operations of USD 0.02 a year ago.
Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.
HYPHA LABS, INC. 
